These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 12370658

  • 1. The molecular genetics of pancreatic ductal carcinoma.
    Sohn TA.
    Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
    [Abstract] [Full Text] [Related]

  • 2. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV, Basturk O, Cheng JD, Andea AA.
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [Abstract] [Full Text] [Related]

  • 3. Where and when does pancreatic carcinoma start?
    Lüttges J, Hahn S, Klöppel G.
    Med Klin (Munich); 2004 Apr 15; 99(4):191-5. PubMed ID: 15085289
    [Abstract] [Full Text] [Related]

  • 4. Molecular pathogenesis of pancreatic cancer.
    Maitra A, Kern SE, Hruban RH.
    Best Pract Res Clin Gastroenterol; 2006 Apr 15; 20(2):211-26. PubMed ID: 16549325
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L, Sanderson SO, Lloyd RV, Smyrk TC.
    Am J Surg Pathol; 2007 Aug 15; 31(8):1191-5. PubMed ID: 17667542
    [Abstract] [Full Text] [Related]

  • 6. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
    Biankin AV, Kench JG, Dijkman FP, Biankin SA, Henshall SM.
    Pathology; 2003 Feb 15; 35(1):14-24. PubMed ID: 12701679
    [Abstract] [Full Text] [Related]

  • 7. [Biological aspects of pancreatic cancer].
    Tonel E, Carbone A, Scirelli T, Bellone G, Emanuelli G.
    Minerva Med; 2005 Apr 15; 96(2):87-94. PubMed ID: 16172578
    [Abstract] [Full Text] [Related]

  • 8. [Precursors to pancreatic cancer].
    Søreide K, Immervoll H, Molven A.
    Tidsskr Nor Laegeforen; 2006 Mar 23; 126(7):905-8. PubMed ID: 16554881
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47.
    Maitra A, Iacobuzio-Donahue C, Rahman A, Sohn TA, Argani P, Meyer R, Yeo CJ, Cameron JL, Goggins M, Kern SE, Ashfaq R, Hruban RH, Wilentz RE.
    Am J Clin Pathol; 2002 Jul 23; 118(1):52-9. PubMed ID: 12109856
    [Abstract] [Full Text] [Related]

  • 10. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J, Niu J, Li M, Chiao PJ, Tsao MS.
    Cancer Res; 2005 Jun 15; 65(12):5045-53. PubMed ID: 15958547
    [Abstract] [Full Text] [Related]

  • 11. Molecular aspects of carcinogenesis in pancreatic cancer.
    Koliopanos A, Avgerinos C, Paraskeva C, Touloumis Z, Kelgiorgi D, Dervenis C.
    Hepatobiliary Pancreat Dis Int; 2008 Aug 15; 7(4):345-56. PubMed ID: 18693168
    [Abstract] [Full Text] [Related]

  • 12. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K, Vickers SM, Adsay NV, Jhala NC, Kim HG, Schoeb TR, Grizzle WE, Klug CA.
    Cancer Res; 2007 Sep 01; 67(17):8121-30. PubMed ID: 17804724
    [Abstract] [Full Text] [Related]

  • 13. Molecular diagnosis of pancreatic cancer.
    Inoue S, Tezel E, Nakao A.
    Hepatogastroenterology; 2001 Sep 01; 48(40):933-8. PubMed ID: 11490843
    [Abstract] [Full Text] [Related]

  • 14. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
    Maitra A, Adsay NV, Argani P, Iacobuzio-Donahue C, De Marzo A, Cameron JL, Yeo CJ, Hruban RH.
    Mod Pathol; 2003 Sep 01; 16(9):902-12. PubMed ID: 13679454
    [Abstract] [Full Text] [Related]

  • 15. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
    Tomaszewska R.
    Folia Med Cracov; 1999 Sep 01; 40(1-2):101-41. PubMed ID: 10909469
    [Abstract] [Full Text] [Related]

  • 16. The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types.
    Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE.
    Cancer Res; 2002 Sep 15; 62(18):5351-7. PubMed ID: 12235006
    [Abstract] [Full Text] [Related]

  • 17. Precursor lesions in pancreatic cancer: morphological and molecular pathology.
    Scarlett CJ, Salisbury EL, Biankin AV, Kench J.
    Pathology; 2011 Apr 15; 43(3):183-200. PubMed ID: 21436628
    [Abstract] [Full Text] [Related]

  • 18. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
    Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, Aoyagi S, Kinoshita H, Kuwano M.
    Cancer Res; 2006 Jun 15; 66(12):6233-42. PubMed ID: 16778198
    [Abstract] [Full Text] [Related]

  • 19. Molecular changes in pancreatic cancer.
    Buchholz M, Gress TM.
    Expert Rev Anticancer Ther; 2009 Oct 15; 9(10):1487-97. PubMed ID: 19828010
    [Abstract] [Full Text] [Related]

  • 20. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC, Klimstra DS, Varmus HE.
    Genes Dev; 2003 Dec 15; 17(24):3127-38. PubMed ID: 14681205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.